116 related articles for article (PubMed ID: 27811020)
1. Impact of CTLA4 genotype and other immune response gene polymorphisms on outcomes after single umbilical cord blood transplantation.
Cunha R; Zago MA; Querol S; Volt F; Ruggeri A; Sanz G; Pouthier F; Kogler G; Vicario JL; Bergamaschi P; Saccardi R; Lamas CH; Díaz-de-Heredia C; Michel G; Bittencourt H; Tavella M; Panepucci RA; Fernandes F; Pavan J; Gluckman E; Rocha V;
Blood; 2017 Jan; 129(4):525-532. PubMed ID: 27811020
[TBL] [Abstract][Full Text] [Related]
2. Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation.
Sanz J; Jaramillo FJ; Planelles D; Montesinos P; Lorenzo I; Moscardó F; Martin G; López F; Martínez J; Jarque I; de la Rubia J; Larrea L; Sanz MA; Sanz GF
Biol Blood Marrow Transplant; 2014 Jan; 20(1):106-10. PubMed ID: 24516896
[TBL] [Abstract][Full Text] [Related]
3. Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis.
Eapen M; Wang T; Veys PA; Boelens JJ; St Martin A; Spellman S; Bonfim CS; Brady C; Cant AJ; Dalle JH; Davies SM; Freeman J; Hsu KC; Fleischhauer K; Kenzey C; Kurtzberg J; Michel G; Orchard PJ; Paviglianiti A; Rocha V; Veneris MR; Volt F; Wynn R; Lee SJ; Horowitz MM; Gluckman E; Ruggeri A
Lancet Haematol; 2017 Jul; 4(7):e325-e333. PubMed ID: 28623181
[TBL] [Abstract][Full Text] [Related]
4. Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
Yamamoto H; Uchida N; Matsuno N; Ota H; Kageyama K; Wada S; Kaji D; Nishida A; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Yamamoto G; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1634-40. PubMed ID: 24972251
[TBL] [Abstract][Full Text] [Related]
5. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
[TBL] [Abstract][Full Text] [Related]
6. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.
Eapen M; Klein JP; Sanz GF; Spellman S; Ruggeri A; Anasetti C; Brown M; Champlin RE; Garcia-Lopez J; Hattersely G; Koegler G; Laughlin MJ; Michel G; Nabhan SK; Smith FO; Horowitz MM; Gluckman E; Rocha V; ; ;
Lancet Oncol; 2011 Dec; 12(13):1214-21. PubMed ID: 21982422
[TBL] [Abstract][Full Text] [Related]
7. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.
Eapen M; Klein JP; Ruggeri A; Spellman S; Lee SJ; Anasetti C; Arcese W; Barker JN; Baxter-Lowe LA; Brown M; Fernandez-Vina MA; Freeman J; He W; Iori AP; Horowitz MM; Locatelli F; Marino S; Maiers M; Michel G; Sanz GF; Gluckman E; Rocha V;
Blood; 2014 Jan; 123(1):133-40. PubMed ID: 24141369
[TBL] [Abstract][Full Text] [Related]
8. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
[TBL] [Abstract][Full Text] [Related]
9. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
[TBL] [Abstract][Full Text] [Related]
10. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
[TBL] [Abstract][Full Text] [Related]
11. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial.
Koreth J; Kim HT; Lange PB; Bindra B; Reynolds CG; Chammas MJ; Armand P; Cutler CS; Ho VT; Glotzbecker B; Nikiforow S; Ritz J; Blazar BR; Soiffer RJ; Antin JH; Alyea EP
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1907-13. PubMed ID: 26055298
[TBL] [Abstract][Full Text] [Related]
12. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P
Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796
[TBL] [Abstract][Full Text] [Related]
13. "No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment.
Dahi PB; Ponce DM; Devlin S; Evans KL; Lubin MN; Gonzales AM; Tonon J; Meagher R; Giralt S; Kernan NA; Scaradavou A; Barker JN
Biol Blood Marrow Transplant; 2014 Apr; 20(4):490-4. PubMed ID: 24361912
[TBL] [Abstract][Full Text] [Related]
14. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
15. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
16. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
[TBL] [Abstract][Full Text] [Related]
17. Allele-Level HLA Matching Impacts Key Outcomes Following Umbilical Cord Blood Transplantation for Inherited Metabolic Disorders.
Mallhi KK; Smith AR; DeFor TE; Lund TC; Orchard PJ; Miller WP
Biol Blood Marrow Transplant; 2017 Jan; 23(1):119-125. PubMed ID: 27989932
[TBL] [Abstract][Full Text] [Related]
18. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
[TBL] [Abstract][Full Text] [Related]
19. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
Sanz J; Boluda JC; Martín C; González M; Ferrá C; Serrano D; de Heredia CD; Barrenetxea C; Martinez AM; Solano C; Sanz MA; Sanz GF;
Bone Marrow Transplant; 2012 Oct; 47(10):1287-93. PubMed ID: 22327127
[TBL] [Abstract][Full Text] [Related]
20. [The impact of HLA matching on outcome of single unit unrelated cord blood transplantation: a retrospective single center clinical analysis].
Sun G; Sun Z; Liu H; Zheng C; Tang B; Zhu X; Song K
Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):678-83. PubMed ID: 25152111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
